Senior Particle Scientist
AstraZeneca
·Today
- Location
- Macclesfield, England,GB, GB
- Type
- Full-time
- Department
- Education
- Seniority
- Senior
- Education
- PhD
- Source
- Eightfold
Description
Introduction to role:
Are you a particle scientist ready to turn complex materials into medicines that reach patients faster? Join us to define and deliver the critical particle attributes that enable robust drug substance processing and dependable drug product performance.
Based at our Macclesfield campus, you will be a core member of our Early Chemical Development team within Pharmaceutical Sciences. Day to day, you will lead experimental design and material characterisation, shape strategies at the Drug Substance–Drug Product interface, and work flexibly across laboratories and our Large-Scale Laboratory. You will also influence external work by guiding particle size reduction, particle engineering and characterisation at CDMOs worldwide.
This is a hands-on laboratory role with visible impact on program speed, manufacturability and patient outcomes. You will develop new methodologies, build capability for amorphous and hard-to-crystallise materials, and help establish how particle data is governed and used to drive modelling and AI-enabled decision making. Will you be the scientific voice that de‑risks particle properties from first campaigns through Phase 3?
Accountabilities:
- Ensures own work is performed in accordance with appropriate Safety, Health & Environment (SHE), quality and compliance standards, e.g. Good Laboratory Practice (GLP) or GMP as required.
- Works as a member of cross-functional teams, with a large degree of independence representing Drug Substance Materials Science on project teams. Collaborative working is expected with specialists in areas such as chemistry, engineering, analytical, crystallisation science, solid state, biopharmaceutics and formulation to build process understanding from an API perspective.
- Contributes to programs of experimental work to characterise and understand the pharmaceutical properties (physicochemical and biopharm) of drug substances and formulations in a timely fashion and to agreed quality standards by applying a wide range of material characterisation techniques.
- Leads the assessment of API particle property risks, development and delivery of Drug Substance to Drug Product Departments via clear plans and strategies to support drug projects.
- Work closely with our colleagues in Supply Chain and our Contract Development and Manufacturing Organisations (CDMOs) across the globe, providing input in terms of API/material science/physical attributes into process development.
- Oversees the use of appropriate Drug Substance material characterisation methodologies and specifications for the manufacture of batches for discovery, pre-clinical or clinical use as required.
- Assesses, reviews and reports data from own work and work of junior colleagues, with a clear understanding of its reliability. Interprets findings and draws authoritative conclusions and recommendations so that their significance can be appreciated in a timely fashion. Leads the authoring of development reports, and contributions to regulatory documentation as required.
- Supports on-going management of change and associated risk in own work area
- Provides technical expertise to dry particle size reduction (PSR) and particle-engineering strategies for Drug Substance projects including make-versus-buy recommendations.
- Support project acceleration by characterising particle properties from the earliest development stages, including material from first campaigns used for formulation development, so that performance can be interpreted and risks managed as projects progress.
Science and Technology Advancement & Skill Area Strategic Direction
- Develop an understanding of the link between critical particle properties, process robustness and performance, including the impact of Drug Substance variability to drug product performance at the Drug Substance/Drug Product interface.
- Build capability to characterise, control and manufacture amorphous and difficult-to-crystallise materials, developing appropriate characterisation strategies and improving understanding of amorphous behaviour, stability and process performance.
- As a member of a global department and network, identify, evaluate and implement state of the art characterisation approaches to build and improve API material science capability. May be expected to influence colleagues in other areas/functions and/or in external groups.
- Develop links with external collaborators to advance API material science capability.
- Provide training/guidance to other scientists on technical and functional processes
- Develops awareness of novel particle characterisation techniques and implements as business-as-usual when beneficial.
- Provide scientific oversight of outsourced particle-engineering, PSR and particle characterisation activities, including defining technical requirements, assessing technical risk, overseeing method transfer and comparability assessments, challenging and reviewing CDMO data, and supporting technology transfer and end-to-end supply chain strategies.
- Develops expertise in dry particle size reduction (PSR) and particle-engineering technologies for Drug Substance projects.
Essential Skills/Experience:
- Degree (BSc and 3 years' experience, or PhD) in Material or Particle Science or a related subject. Equivalent experience will be considered.
- Enthusiam to work in the lab
- Proven hands on experience of particle characterisation techniques such as Particle Size and Shape Distribution (laser diffraction, Static/Dynamic Image analysis), flow, bulk properties and broader awareness of material science areas such as colloid and interface science, soft matter characterisation, imaging, etc which can be applied to any APIs.
- Proven experience of developing relationships between API physical/material attributes and product processing/product performance.
- Understanding of GMP
- Practical hands on experience of particle size reduction (e.g. milling, micronisation) and other particle-engineering technologies, including how process parameters influence particle properties.
- Proven hands-on experience experience of developing and validating particle size analytical methods (e.g. laser diffraction) and applying PSD data to define control strategies.
- Ability to tackle complex scientific problems and troubleshooting.
- Strong communication, collaboration stakeholder management skills, and the ability to discuss complex ideas in a simple, easy to understand way.
- Applied knowledge of particle property prediction techniques
Desirable Skills/Experience:
- Knowledge and industrial experience of pharmaceutical development and regulatory submissions.
- Knowledge of processes used for Drug Substance and Drug Product manufacture.
- Understanding of solid state properties that are linked to material behaviour
- Experience of characterising amorphous or difficult-to-crystallise materials.
- Experience of working with CDMOs or external partners, including method transfer, technology transfer and data review.
- Interest in data management, data governance or digital/modelling tools applied to particle data.
- Strong influencing skills and prioritisation skills to ensure project delivery
- A track record of scientific excellence in terms of publications and/or conference presentations.
Why AstraZeneca:
Here, your materials science expertise fuels medicines with the potential to change millions of lives. You will work in an environment where curiosity and courage are matched with real resources, where unexpected teams sit around the same bench to unlock bold ideas, and where digital, data science and AI amplify great experimental work. We value kindness alongside ambition, and we back lifelong learning with access to diverse modalities, stages of development and genuine opportunities to publish and shape the field. Your contribution won’t sit on a shelf—it will move through an agile pipeline with collaborators from academia, biotechs and industry, turning rigorous science into tangible patient impact.
Call to Action:
If you are ready to shape particle properties that shape outcomes—and grow your influence from the lab to regulatory impact—send your CV and show us how you will accelerate medicines to patients!
Date Posted
17-nov.-2026
Closing Date
01-dez.-2026
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.